183 related articles for article (PubMed ID: 26883924)
1. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
Lau CL; Streeton CL; David MC; Sly PD; Mills DJ
J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
[TBL] [Abstract][Full Text] [Related]
2. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
Loebermann M; Kollaritsch H; Ziegler T; Rendi-Wagner P; Chambonneau L; Dumas R; Lafrenz M
Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
[TBL] [Abstract][Full Text] [Related]
3. Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children.
Furuya-Kanamori L; Dutton P; Leeb A; Mills DJ; Andrews R; Lau CL
J Pediatric Infect Dis Soc; 2021 Mar; 10(2):192-195. PubMed ID: 32333678
[TBL] [Abstract][Full Text] [Related]
4. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
Overbosch D; Peyron F; Picot N; Varichon JP; Dumas R; Chambonneau L; Weber F
J Travel Med; 2005; 12(6):319-26. PubMed ID: 16343383
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
[TBL] [Abstract][Full Text] [Related]
6. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
Proell S
BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
[No Abstract] [Full Text] [Related]
7. A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults.
Beran J; Chlibek R; Weber F
Vaccine; 2003 Dec; 21(32):4650-4. PubMed ID: 14585671
[TBL] [Abstract][Full Text] [Related]
8. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
[TBL] [Abstract][Full Text] [Related]
9. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
[TBL] [Abstract][Full Text] [Related]
10. New and improved vaccines. Promising weapons against varicella, hepatitis A, and typhoid fever.
Conrad DA; Jenson HB
Postgrad Med; 1996 Oct; 100(4):113-8, 121-5, 127. PubMed ID: 8858086
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
[TBL] [Abstract][Full Text] [Related]
13. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
[TBL] [Abstract][Full Text] [Related]
14. Safety of Typhim Vi vaccine in a postmarketing observational study.
Marcus LC; Froeschle JE; Hill DR; Wolfe MS; Maus D; Connor B; Acosta AM; Rensimer ER; Roberts A; Dardick K
J Travel Med; 2007; 14(6):386-91. PubMed ID: 17995534
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis and typhoid vaccine: killing two birds with one stone.
Tucker R
Community Nurse; 1999 Nov; 5(10):41-2. PubMed ID: 10732550
[No Abstract] [Full Text] [Related]
17. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
Miyazu M; Kikuchi H; Hamada A; Fukushima S; Ouchi K; Bosch Castells V; Mihara H; Bonnet MC
Vaccine; 2015 Nov; 33(48):6697-702. PubMed ID: 26518404
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
[TBL] [Abstract][Full Text] [Related]
20. Interchangeability of Hepatitis A boosters, Avaxim and Vaqta, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim.
Ekwall E; Ulgemo A; Watson M; Boisnard F; Thomas S; Goullet F
Vaccine; 2006 May; 24(20):4450-7. PubMed ID: 16621186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
